ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 257.6 | 218.0 | 226.4 |
| Other income | 16.8 | 17.8 | 17.9 |
| Total income | 274.4 | 235.8 | 244.4 |
| Profit before exceptional items & tax | 28.9 | 26.0 | 17.7 |
| Exceptional items | 0.0 | 3.5 | 0.0 |
| Profit before tax | 28.9 | 29.5 | 17.7 |
| Net profit | 21.3 | 21.8 | 13.0 |
| Operating margin | 10.5% | 12.5% | 7.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +63.80% |
|---|---|
| Net profit, quarter on quarter | -2.30% |
| Revenue, year on year | +13.80% |
| Operating profit, year on year | +6150.00% |
| Operating profit, quarter on quarter | +47.60% |
BSE results filing, NSE: TTKHLTCARE. Figures extracted from the filing.
TTK Healthcare Ltd: key numbers
- Share price
- ₹959.40
- Market cap
- ₹1,356 Cr
- Revenue (annual)
- ₹857.3 Cr
- Net profit (annual)
- ₹65.68 Cr
- P/E (TTM)
- 4.9×Sector 22.4×
- Promoter holding
- 74.56%+0.00% QoQ
- FII holding
- 1.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TTK Healthcare Ltd
All →TTK Healthcare Q2 FY27 Results: Net Profit ₹223 Cr, Up 993.1% YoY
TTK Healthcare Ltd reported revenue from operations of ₹233.4 Cr (+14.6% YoY) and net profit of ₹223 Cr (+993.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹223 Cr · +993.1% YoY
TTK Healthcare Board Meeting Date
TTK Healthcare will hold a board meeting on 30 October 2026 to consider unaudited financial results for the second quarter ended September 30, 2026. The trading window stays closed from 01 October to 01 November 2026.
TTK Healthcare Other Announcement
TTK Healthcare Limited has filed the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
TTK Healthcare Merger & Restructuring Worth ₹256 Cr
TTK Healthcare completed the sale of its "EVA" and "Good Home" brands to Wipro Enterprises. The company received Rs. 256 crore in cash consideration.
- Value
- ₹256.0 Cr
TTK Healthcare Other Announcement
TTK Healthcare Limited has appointed M/s. R V K & Co., Chartered Accountants, as the Company's Tax Auditor. The appointment is for a three-year term covering FY 2025-26 to 2027-28.
- Execution
- 3 years
TTK Healthcare Management Change
TTK Healthcare Ltd announced that its tax auditor, M/s Aiyar & Co., resigned effective August 26, 2026. The auditor cited eligibility issues regarding their peer review certificate.